This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Martin Hessling: Innovator in DNA Analysis Technology
Introduction
Martin Hessling is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of DNA analysis, particularly through his innovative patent that enhances the imaging of fluorescence signals. His work has implications for various applications in genetic research and diagnostics.
Latest Patents
Hessling holds a patent titled "Imaging fluorescence signals using telecentricity." This invention focuses on a device designed for the parallel imaging of fluorescence intensities at multiple sites, serving as a measure for DNA hybridization. More specifically, it is aimed at imaging multiplex real-time PCR and reading DNA microarrays. This patent showcases his expertise in developing advanced technologies for genetic analysis.
Career Highlights
Throughout his career, Martin Hessling has worked with prominent companies in the biotechnology sector. He has been associated with Roche Diagnostics Operations, Inc., a leader in the field of diagnostics, and Pharmpur GmbH, where he contributed to innovative projects. His experience in these organizations has helped him refine his skills and expand his knowledge in DNA analysis technologies.
Collaborations
Hessling has collaborated with notable professionals in his field, including Hans-Georg Heckmann and Joachim Koenig. These collaborations have likely enriched his work and contributed to the development of his innovative solutions in DNA analysis.
Conclusion
Martin Hessling is a distinguished inventor whose work in imaging fluorescence signals has advanced the field of DNA analysis. His contributions through patents and collaborations reflect his commitment to innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
